Fragment-based drug discovery in an integrated informatics environment

webinar

Wed, 25 Jan 2017, 16:00 CET (Berlin)

Marcel Verdonk, Senior Director, Astex Therapeutics, Cambridge, UK

Fragment-based drug discovery in an integrated informatics environment

From the outset, Astex have committed to developing a highly integrated informatics platform for fragment-based drug discovery. This ensures scientists from all disciplines have all relevant data at their fingertips, and creates an environment that democratizes the drug-discovery process. Here, we will discuss a number of tools that we have developed to achieve this. These range from chemoinformatics approaches to improve our fragment library and assist in the hit-validation stages of a project, to the use of protein-ligand structural databases for hit-to-lead optimization.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on